课题基金 / 基金详情

ANTI TNF ANTIBODY D2E7 IV INJECTION IN RHEUMATOID ARTHRITIS

ANTI TNF ANTIBODY D2E7 IV INJECTION IN RHEUMATOID ARTHRITIS
抗TNF抗体D2E7静脉注射治疗类风湿性关节炎
批准号:
6265190
负责人:
MICHAEL H WEISMAN
金额:
$1.15万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

MICHAEL H WEISMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Investigate the clinical pharmacology profile, safety, tolerability, immunogenicity and early signs of clinical efficacy following repeated administration of ascending doses of D2E7 in patients with rheumatoid arthritis treated concomitantly with methotrexate. Evaluate onset, magnitude and duration of effects of a combination of D2E7 and methotrexate on inflammatory synovitis, assessed by standard clinical and laboratory parameters.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RECOMBINANT HUMAN INTERLEUKIN ELEVEN IN RHEUMATOID ARTHRITIS
STUDY OF ORAL CCII IN TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS
INDUCTION COURSE & MAINTENANCE CYCLE OF AG4263 IN RHEUMATOID ARTHRITIS
LJP 394 ADMINISTERED TO PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
海外基金